GHRP-6 (5mg x 10), Ipamorelin (5mg x 10)

$697.00

& Free Shipping

GHRP-6 and Ipamorelin are synthetic research peptides commonly used together in experimental models to investigate growth hormone axis regulation and pituitary receptor signaling. GHRP-6 is a hexapeptide growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R1a), engaging Gq/PLC-dependent calcium signaling pathways involved in GH release and hypothalamic–pituitary feedback mechanisms. Ipamorelin is a selective pentapeptide GHS-R1a agonist that promotes GH secretion through calcium-mediated signaling while exhibiting minimal interaction with other pituitary hormone systems in preclinical research. The combined use of GHRP-6 and Ipamorelin enables investigation of complementary GHS-R1a signaling dynamics, receptor pharmacology, and somatotropic pathway modulation.

For research use only. Not for human consumption.

References:
Bowers CY et al., Ann NY Acad Sci, 1998 865:244–249
Smith RG et al., Science, 1997 275(5304):1261–1264
Svensson J et al., J Endocrinol Invest, 1998 21(9):692–699

Category:

What you’re asking for

GHRP-6 (5mg × 10) + Ipamorelin (5mg × 10)

This is typically sold as a growth hormone secretagogue stack, meaning two peptides that stimulate natural growth hormone (GH) release through different receptors:

  • GHRP-6 → ghrelin receptor agonist
  • Ipamorelin → selective ghrelin receptor agonist (more “targeted” profile in research)

What this combo actually is (research context)

  • Strong growth hormone pulse stimulator
  • Also strongly linked to increased appetite signaling (ghrelin pathway)
  • One of the earlier GH-releasing peptides studied in labs

  • More selective GH secretagogue
  • Designed to stimulate GH release with fewer off-target hormone effects in research models

Why they’re often compared or paired

In research discussions:

  • Both act on the GH axis
  • Both stimulate pulsatile growth hormone release
  • They differ mainly in potency profile and side effects seen in studies

But importantly:
👉 They are not approved medications or standardized treatments


What “5mg × 10 vials” means

Listings like this usually mean:

  • 10 separate vials per peptide
  • Each vial contains 5mg freeze-dried powder
  • Total batch:
    • 50mg GHRP-6
    • 50mg Ipamorelin

From real-world vendors, these are explicitly labeled:

“Research use only, not for human consumption” (Nextech Labs®)

And are sold as lyophilized laboratory peptides, not finished pharmaceutical products.


Important reality check

Even though marketing makes them look clinical:

  • ❌ Not FDA-approved
  • ❌ Not regulated for consumer use
  • ❌ No standardized human dosing protocols
  • ✔ Classified as research chemicals

Even peer discussions emphasize variability in quality and labeling across suppliers.


Risks people often ignore

  • Unregulated manufacturing quality
  • Mislabeling of peptide content or ratios
  • No long-term safety data in non-clinical use
  • Effects on hormone axis are not fully predictable outside research settings

Key takeaway

  • is a research-only combination used to study growth hormone release through the ghrelin receptor pathway, but “5mg × 10 vial” products are unregulated laboratory materials—not approved medicines, supplements, or safe consumer products.

ghrp 6 (5mg x 10), ipamorelin (5mg x 10)ghrp 6 (5mg x 10), ipamorelin (5mg x 10)ghrp 6 (5mg x 10), ipamorelin (5mg x 10)

Shopping Cart